RELATED CONTENT
NEWS
- Synageva goes public in an all-stock merger with struggling Trimeris
- Synageva makes public spectacle with $60 million stock offer after Trimeris merger
- BMS fronts up $24M for Ambrx 'biobetters' in heart failure and type 2 diabetes
- Daiichi Sankyo builds diabetes position with NGM research alliance
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

